(Q41540977)

English

Somatostatin analog RC-160 and bombesin/gastrin-releasing peptide antagonist RC-3095 inhibit the growth of androgen-independent DU-145 human prostate cancer line in nude mice

scientific article published on July 1993

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

2 October 2017

Somatostatin analog RC-160 and bombesin/gastrin-releasing peptide antagonist RC-3095 inhibit the growth of androgen-independent DU-145 human prostate cancer line in nude mice (English)

1 reference

Europe PubMed Central

PubMed publication ID

2 October 2017

3

1 reference

Europe PubMed Central

PubMed publication ID

2 October 2017

author name string

J Pinski

1

1 reference

Europe PubMed Central

PubMed publication ID

2 October 2017

G Halmos

2

1 reference

Europe PubMed Central

PubMed publication ID

2 October 2017

language of work or name

0 references

publication date

1 July 1993

1 reference

Europe PubMed Central

PubMed publication ID

2 October 2017

1 reference

Europe PubMed Central

PubMed publication ID

2 October 2017

71

1 reference

Europe PubMed Central

PubMed publication ID

2 October 2017

1-3

1 reference

Europe PubMed Central

PubMed publication ID

2 October 2017

189-196

1 reference

Europe PubMed Central

PubMed publication ID

2 October 2017

Isolation of a human prostate carcinoma cell line (DU 145)

1 reference

24 May 2022

https://opencitations.net/index/coci/api/v1/citations/10.1002/IJC.2910210305

Growth inhibition of estrogen-dependent and estrogen-independent MXT mammary cancers in mice by the bombesin and gastrin-releasing peptide antagonist RC-3095

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/0304-3835(93)90115-P

Prostate Cancer: continuing progress

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/0304-3835(93)90115-P

IGF-I and IGF-binding proteins: stimulatory and inhibitory factors secreted by human prostatic adenocarcinoma cells

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/0304-3835(93)90115-P

Pseudononapeptide bombesin antagonists containing C-terminal Trp or Tpi

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/0304-3835(93)90115-P

Production of epidermal growth factor and transforming growth factor-alpha by the androgen-responsive LNCaP human prostate cancer cell line

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/0304-3835(93)90115-P

Growth factor involvement and oncogene expression in prostatic tumours

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/0304-3835(93)90115-P

Role of transforming growth factor-alpha in human prostate cancer cell growth

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/0304-3835(93)90115-P

Binding of epidermal growth factor by human normal, hypertrophic, and carcinomatous prostate

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/0304-3835(93)90115-P

Secretion of epidermal growth factor and related polypeptides by the DU 145 human prostate cancer cell line

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/0304-3835(93)90115-P

Inhibition of growth of experimental prostate cancer in rats by LH-RH analogs linked to cytotoxic radicals

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/0304-3835(93)90115-P

Bombesin stimulates growth of human prostatic cancer cells in vitro

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/0304-3835(93)90115-P

Characterization, in some human breast cancer cell lines, of gastrin-releasing peptide-like receptors which are absent in normal breast epithelial cells

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/0304-3835(93)90115-P

Cancer statistics, 1992

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/0304-3835(93)90115-P

The importance of prognostic factors in advanced prostate cancer

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/0304-3835(93)90115-P

The response to chemotherapy of a variety of human tumour xenografts

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/0304-3835(93)90115-P

Receptors for luteinizing hormone-releasing hormone, somatostatin, prolactin, and epidermal growth factor in rat and human prostate cancers and in benign prostate hyperplasia

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/0304-3835(93)90115-P

Inhibition of growth of PC-82 human prostate cancer line xenografts in nude mice by bombesin antagonist RC-3095 or combination of agonist [D-Trp6]-luteinizing hormone-releasing hormone and somatostatin analog RC-160

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/0304-3835(93)90115-P

Effect of microcapsules of luteinizing hormone-releasing hormone antagonist SB-75 and somatostatin analog RC-160 on endocrine status and tumor growth in the Dunning R-3327H rat prostate cancer model

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/0304-3835(93)90115-P

Present status of agonistic and antagonistic analogs of LH-RH in the treatment of advanced prostate cancer

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/0304-3835(93)90115-P

The timing of androgen ablation therapy and/or chemotherapy in the treatment of prostatic cancer

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/0304-3835(93)90115-P

Identifiers

10.1016/0304-3835(93)90115-P

1 reference

Europe PubMed Central

PubMed publication ID

2 October 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

2 October 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q41540977&oldid=1924126304"